Abstract:Endoplasmic reticulum stress (ERS), which refers to a series of adaptive responses to the disruption of endoplasmic reticulum (ER) homeostasis, occurs when cells are treated by drugs or undergo microenvironmental changes that cause the accumulation of unfolded/misfolded proteins. ERS is one of the key responses during the drug treatment of solid tumors. Drugs induce ERS by reactive oxygen species (ROS) accumulation and Ca 2+ overload. The unfolded protein response (UPR) is one of ERS. Studies have indicated that the mechanism of ERS-mediated drug resistance is primarily associated with UPR, which has three main sensors (PERK, IRE1α, and ATF6). ERS-mediated drug resistance in solid tumor cells is both intrinsic and extrinsic. Intrinsic ERS in the solid tumor cells, the signal pathway of UPR-mediated drug resistance, includes apoptosis inhibition signal pathway, protective autophagy signal pathway, ABC transporter signal pathway, Wnt/β-Catenin signal pathway, and noncoding RNA. Among them, apoptosis inhibition is one of the major causes of drug resistance. Drugs activate ERS and its downstream antiapoptotic proteins, which leads to drug resistance. Protective autophagy promotes the survival of solid tumor cells by devouring the damaged organelles and other materials and providing new energy for the cells. ERS induces protective autophagy by promoting the expression of autophagy-related genes, such as Beclin-1 and ATG5–ATG12. ABC transporters pump drugs out of the cell, which reduces the drug-induced apoptosis effect and leads to drug resistance. In addition, the Wnt/β-catenin signal pathway is also involved in the drug resistance of solid tumor cells. Furthermore, noncoding RNA regulates the ERS-mediated survival and death of solid tumor cells. Extrinsic ERS in the solid tumor cells, such as ERS in immune cells of the tumor microenvironment (TME), also plays a crucial role in drug resistance by triggering immunosuppression. In immune system cells, ERS in dendritic cells (DCs) and myeloid-derived suppressor cells (MDSCs) influences the antitumor function of normal T cells, which results in immunosuppression. Meanwhile, ERS in T cells can also cause impaired functioning and apoptosis, leading to immunosuppression. In this review, we highlight the core molecular mechanism of drug-induced ERS involved in drug resistance, thereby providing a new strategy for solid tumor treatment.

Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma

Endoplasmic Reticulum Stress: Multiple Regulatory Roles in Hepatocellular Carcinoma

Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects

Autophagy Plays a Critical Role in Insulin Resistance- Mediated Chemoresistance in Hepatocellular Carcinoma Cells by Regulating the ER Stress.

Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy

Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells

Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration

ER stress signaling at the interphase between MASH and hepatocellular carcinoma

Targeting Metabolic Reprogramming in Hepatocellular Carcinoma to Overcome Therapeutic Resistance: A Comprehensive Review

Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactions

Epithelial–mesenchymal Transition Plays a Critical Role in Drug Resistance of Hepatocellular Carcinoma Cells to Oxaliplatin

The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance

Endoplasmic Reticulum Stress in Liver Diseases

Involvement of the Epidermal Growth Factor Receptor in the Modulation of Multidrug Resistance in Human Hepatocellular Carcinoma Cells in Vitro

The endoplasmic reticulum stress response is associated with insulin resistance-mediated drug resistance in HepG2 cells.

Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma.

Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis

Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance

Insulin Resistance Contributes to Multidrug Resistance in HepG2 Cells Via Activation of the PERK Signaling Pathway and Upregulation of Bcl-2 and P-gp.

Endoplasmic Reticulum Stress Regulates Tumor Growth and Anti-Tumor Immunity: a Promising Opportunity for Cancer Immunotherapy

Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy